At present, Zhongzhi Pharmaceutical Co., Ltd. has six dosage forms: tablet, capsule, granule, syrup, mixture and tea, with a comprehensive annual output value of 2 billion yuan. There are more than 50 kinds of Chinese patent medicines, including Zhongzhi brand Keke tablets, antibacterial and anti-inflammatory capsules, anti-inflammatory and cough-relieving tablets, etc., as well as Liumian brand Jinji tablets, Jinji granules and Shi Qi Exogenous Tea. There are more than a dozen health products, such as "taste dishes" and "cool throat moistening"; Chinese herbal pieces * * * have over 100 varieties in five series, including Guangdong herbal tea, medicinal soup, superfine powder and teabag, covering health care, health preservation, blood-enriching, qi-invigorating, beauty and other categories.

Sales is the life of an enterprise, and the interests of customers are the foundation of its development. Cizhi marketing focuses on the interests of downstream customers, focuses on service, flexible marketing model, scientific brand management, mature product planning, perfect market management mechanism and efficient after-sales service. These are all important parts of serving customers and safeguarding their interests. The brand concept of "no regret medicine" is the interpretation of these ingredients and many years of sales experience. It creates the wisdom that "what is suitable is the best". Guided by this, Zhongzhi Pharmaceutical is committed to achieving the goal of "big family, big market, great benefit and great pursuit" and has built a sales network all over the country.

Since its establishment, Zhongzhi Pharmaceutical Group has been focusing on the development of traditional Chinese medicine, promoting the quintessence of Chinese medicine, aiming at building the "flagship project of traditional Chinese medicine", with the highest goal of building the best traditional Chinese medicine industry group in China. At present, the enterprise has completed the construction of the top ten pharmaceutical enterprises in Guangdong Province, the industrial chain of GAP, GMP and GSP standard drugs production and operation, and the construction of provincial engineering centers, completed the strategic goal of independent intellectual property technology and product research and development, and continuously upgraded to a higher competitive platform.